Latest news with #MitsuiChemicals
Business Insider
3 days ago
- Business
- Business Insider
Goldman Sachs Keeps Their Hold Rating on Mitsui Chemicals (MITUF)
Goldman Sachs analyst Atsushi Ikeda maintained a Hold rating on Mitsui Chemicals (MITUF – Research Report) yesterday and set a price target of Yen4,000.00. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Ikeda is ranked #7707 out of 9552 analysts. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Mitsui Chemicals with a $28.46 average price target. Based on Mitsui Chemicals' latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $470.33 billion and a GAAP net loss of $5.47 billion. In comparison, last year the company earned a revenue of $475.21 billion and had a net profit of $12.74 billion
Business Insider
3 days ago
- Business
- Business Insider
Mitsui Chemicals (MITUF) Receives a Buy from Morgan Stanley
Morgan Stanley analyst Takato Watabe maintained a Buy rating on Mitsui Chemicals (MITUF – Research Report) yesterday and set a price target of Yen4,300.00. The company's shares closed last Wednesday at $24.63. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Watabe is a 3-star analyst with an average return of 5.6% and a 50.00% success rate. Currently, the analyst consensus on Mitsui Chemicals is a Moderate Buy with an average price target of $27.11, a 10.07% upside from current levels. In a report released on May 21, UBS also maintained a Buy rating on the stock with a Yen3,900.00 price target. Based on Mitsui Chemicals' latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $470.33 billion and a GAAP net loss of $5.47 billion. In comparison, last year the company earned a revenue of $475.21 billion and had a net profit of $12.74 billion
Yahoo
6 days ago
- Business
- Yahoo
Cyclic Olefin Polymer Market worth $1.54 billion by 2029, at a CAGR of 6.5%, says MarketsandMarkets™
Delray Beach, FL, May 28, 2025 (GLOBE NEWSWIRE) -- The Cyclic Olefin Polymer Market is projected to reach USD 1.54 billion by 2029 from USD 1.12 billion in 2024, at a CAGR of 6.5% during the forecast period, as per the recent study by MarketsandMarkets™. The cyclic olefin polymer (COP) market is growing steadily due to its unique combination of optical clarity, chemical resistance, and mechanical strength, making it a preferred material across multiple industries. COPs offer high transparency, low birefringence, excellent moisture barrier properties, and superior heat resistance, making them ideal for optical lenses, smartphone displays, medical vials, and diagnostic devices. Their low dielectric constant and high thermal stability drive adoption in 5G communication, automotive LiDAR, and advanced electronics. Additionally, COP's lightweight nature, dimensional stability, and biocompatibility position it as a superior alternative to glass and conventional plastics in pharmaceutical, packaging, and high-performance engineering applications. The North American copper tube market is undergoing significant change with advancements in technology, regulatory changes, and changing industry needs. Technologically, the market is experiencing a shift toward MicroGroove technology, where smaller-diameter, inner-grooved copper tubes are used to improve the efficiency of heat exchange. The design not only enhances energy efficiency but also allows for the use of natural refrigerants by lowering the total charge of refrigerant needed in systems. In addition, improved manufacturing processes, including extrusion and rolling, have made it possible to manufacture seamless copper tubes with consistent dimensions, which enhance structural strength and optimal performance in HVAC systems. Download PDF Brochure: Browse in-depth TOC on 'Cyclic Olefin Polymer Market' 223 - Market Data Tables 52 – Figures 233 - Pages List of Key Players in Cyclic Olefin Market: Mitsui Chemicals, Inc. (Japan) Polyplastics Co., Ltd. (Japan) Sumitomo Bakelite Co., Ltd. (Japan) JSR Corporation (Japan) Borealis AG (Austria) Polysciences, Inc. (US) Biosynth (Switzerland) Tuoxin Technology (Quzhou) Co., Ltd. (China) Zeon Corporation (China) China Petrochemical Development Corporation (China) Drivers, Opportunities and Challenges in Cyclic Olefin Polymer Market: Drivers: Growing demand in healthcare and pharmaceuticals industry Restraint: High production cost of cyclic olefin polymers Opportunity: Increasing use of cyclic olefin polymers in optical applications Challenge: Volatility of raw material prices Get Sample Pages: Key Findings of the Study: Copolymer is projected to have the largest market share in 2029 Electrical & electronics segment to have the second highest market share in the cyclic olefin polymer market Asia Pacific to be the largest market during the forecast period The cyclic olefin polymer market, by type, is segmented into homopolymers and copolymers. Homopolymers, made from a single type of monomer, provide higher purity, excellent optical clarity, and superior chemical resistance, making them ideal for high-end optical applications, medical devices, and precision electronics. Copolymers, formed by polymerizing two or more monomers, offer greater flexibility, impact resistance, and tailored thermal properties, making them suitable for packaging, automotive components, and high-frequency electronic materials. With rising demand for high-performance materials in advanced technologies, both types are driving market growth across diverse industries. The cyclic olefin polymer market, by process type is segmented into injection molding, extrusion, blow molding and others. Injection molding enables the production of high-precision optical lenses, medical components, and electronic parts due to its excellent dimensional stability and intricate mold detailing. Extrusion is widely used for films, sheets, and high-barrier packaging as COPs offer superior moisture resistance, clarity, and chemical stability. Blow molding is ideal for pharmaceutical vials, diagnostic containers, and specialty bottles, leveraging COP's lightweight, impact resistance, and sterility. With growing demand for high-performance polymers in healthcare, electronics, and packaging, these advanced processing methods are expanding COP's market reach. The cyclic olefin polymer market, by end-use industry type is segmented into packaging, automotive, healthcare & medical, food & beverages, electrical & electronics, chemicals, opticals and others. In packaging, COPs offer excellent moisture barriers and durability, making them ideal for pharmaceutical vials, food containers, and sterile medical packaging. The automotive sector benefits from COP's lightweight, low birefringence, and heat resistance, enhancing LiDAR systems, HUDs, and sensor covers. In healthcare & medical, COPs provide biocompatibility, sterilization resistance, and clarity, making them essential for diagnostic devices, syringes, and labware. Food & beverage applications leverage COP's non-reactivity and superior barrier properties for preserving freshness and extending shelf life. The electrical & electronics industry uses COPs in 5G components, high-frequency circuit boards, and optical films due to their low dielectric constant and high thermal resistance. In chemicals, COP's solvent resistance and mechanical strength support specialty containers and industrial applications. The optical industry relies on COP's low birefringence and clarity for camera lenses, displays, and optical films. With increasing demand across these sectors, COPs continue to drive innovation and market expansion. Get Customization on this Report: The Asia-Pacific region stands out as a major growth hub for the cyclic olefin polymer (COP) market, driven by rapid industrialization, technological advancements, and increasing demand for high-performance materials across various sectors. The region's expanding healthcare, electronics, automotive, and packaging industries are fueling the adoption of COPs due to their superior optical properties, low moisture absorption, excellent chemical resistance, and high thermal stability. As governments invest in infrastructure and advanced manufacturing, and as multinational companies shift production to Asia, the demand for COPs continues to surge. Additionally, favorable government policies, rising consumer awareness, and increased R&D investments in advanced materials are contributing to market expansion. China, being the largest manufacturing powerhouse in the region, plays a crucial role in the COP market. The country's strong electronics and semiconductor industry is driving the demand for COPs in display panels, optical films, and high-frequency circuit materials. With the rapid expansion of 5G networks, electric vehicles (EVs), and advanced medical technologies, the need for high-performance polymers like COPs is rising significantly. Additionally, China's growing pharmaceutical sector, along with its leadership in drug delivery systems and medical device manufacturing, is accelerating COP adoption in syringes, diagnostic consumables, and biopharmaceutical packaging. The government's push for domestic innovation and self-sufficiency in high-performance materials further strengthens the COP market. Japan remains a leading innovator in specialty polymers, with established COP manufacturers like Mitsui Chemicals, Zeon Corporation, and JSR Corporation. The country's advanced medical sector, precision optics industry, and strong semiconductor market create high demand for COP-based materials. Japan's aging population and its emphasis on high-quality medical devices are fueling COP usage in medical packaging, drug delivery systems, and diagnostic instruments. Additionally, Japan's dominance in OLED displays and imaging technologies ensures steady demand for low-birefringence and high-transparency COPs in optical applications. The country's automotive sector, especially in autonomous driving technologies, is also boosting the use of COPs in LiDAR sensors and vehicle lighting systems. India is emerging as a strong market for COPs, particularly in pharmaceuticals, medical devices, and sustainable packaging. The country's booming pharmaceutical industry, driven by rising healthcare investments, regulatory reforms, and increasing demand for high-quality drug packaging, has led to greater adoption of COPs in vials, pre-filled syringes, and diagnostic devices. India's expanding food & beverage sector, combined with a shift toward sustainable and high-barrier packaging materials, is further propelling the demand for COP-based packaging solutions. Additionally, India's Make in India initiative and government incentives for electronics manufacturing are supporting the growth of COP applications in consumer electronics and high-performance polymers for electrical components. South Korea, home to global electronics giants like Samsung and LG, is a key market for COPs in display technologies, semiconductor packaging, and optical films. The country's leadership in OLED and flexible display technologies has increased demand for COPs due to their superior optical clarity and low thermal expansion properties. Additionally, South Korea's growing EV and battery manufacturing sector is driving COP applications in lightweight sensor housings and insulation components. The country's government initiatives to promote advanced materials and semiconductor research further create opportunities for COP manufacturers. Overall, Asia-Pacific is a major driver of the global COP market, with China, Japan, South Korea, and India playing pivotal roles in expanding its applications. The region's fast-paced industrial growth, strong technological advancements, increasing healthcare investments, and booming electronics sector are key factors contributing to the market's expansion. With rising demand for lightweight, high-performance, and sustainable materials, COPs are poised to experience significant growth in medical, electronics, automotive, and packaging applications. As companies continue to innovate and governments push for self-reliant supply chains, the Asia-Pacific region will remain a critical market for cyclic olefin polymers in the years to come. Browse Adjacent Markets Resins and Polymers Market Research Reports & Consulting Related Reports: Wood Coatings Market Synthetic Rope Market Synthetic Leather Market Industrial Fasteners Market Medical Filtration Market CONTACT: About MarketsandMarkets™ MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter, LinkedIn and Facebook. Contact: Mr. Rohan Salgarkar MarketsandMarkets™ INC. 1615 South Congress Ave. Suite 103, Delray Beach, FL 33445, USA: +1-888-600-6441 Email: sales@ Visit Our Website:
Fibre2Fashion
7 days ago
- Business
- Fibre2Fashion
Japan's Mitsui Chemicals plans NF3 exit by March 2026
Mitsui Chemicals, Inc. (Tokyo: 4183; President & CEO: HASHIMOTO Osamu) has decided to withdraw from the nitrogen trifluoride (NF3) business. Currently manufactured by the company's wholly owned subsidiary, Shimonoseki Mitsui Chemicals, Inc. (Shimonoseki, Yamaguchi; President & CEO: YOKAWA Naokazu). Production will cease at the end of March 2026, and sales will end within the same year. Mitsui Chemicals will exit the nitrogen trifluoride (NF3) business by end-2026, ceasing production at its Shimonoseki subsidiary in March. The move aligns with its VISION 2030 plan to shift toward global specialty and green chemicals. Intense price competition, rising input costs, and limited profitability drove the decision despite cost-cutting efforts. Background to the business withdrawal Mitsui Chemicals' VISION 2030 Long-Term Business Plan positions 'Chemistry for Sustainable World' as the company's ideal vision. In pursuing portfolio reform as a basic strategy for achieving this plan, Mitsui Chemicals aims to become a truly global specialty company by leaning on the two key pillars of a high-growth, high-profitability global specialty chemicals business, and a sustainable green chemicals business centered on competitive derivatives. The Semiconductor & Optical Materials Division of Mitsui Chemicals' ICT Solutions Business Sector is engaged in business associated with NF3, a gas used as a cleaning agent for semiconductor and liquid crystal display manufacturing equipment. However, the profitability of the business has been placed under extreme pressure by escalating price competition with overseas products, increasing raw material and utility costs, and rising repair and other costs. In response to this situation, Mitsui Chemicals has undertaken all possible efforts to rationalize the business and reduce costs, but has now determined that it is unfeasible to ensure the level of profitability required to sustain the business and has therefore decided to withdraw from it. Note: The headline, insights, and image of this press release may have been refined by the Fibre2Fashion staff; the rest of the content remains unchanged. Fibre2Fashion News Desk (HU)
Business Upturn
27-05-2025
- Business
- Business Upturn
Mitsui Chemicals Launches New Corporate Venture Capital Fund ‘321Catalyst™'
By Business Wire Published on May 27, 2025, 09:55 IST TOKYO, Japan: Mitsui Chemicals, Inc. (Tokyo: 4183; President & CEO: HASHIMOTO Osamu), a global chemicals manufacturer based in Japan, today announced the launch of its second Corporate Venture Capital Fund '321Catalyst™,' as well as the establishment of a new subsidiary '321Catalyst Ventures, Inc.,' which will manage the fund. Building on the success of its first fund, '321FORCE™,' launched with Japanese venture capital Global Brain in 2022, 321Catalyst™'s mission will be to accelerate the building of global innovation partnerships and the launching of new products and business. Through the establishment of the new, independent fund in the USA, Mitsui Chemicals is doubling down on global investments in innovative startups that align with its strategic focus. Strong innovation partnerships with its portfolio companies will allow Mitsui Chemicals to launch new businesses ahead of the race. 321Catalyst™ will have a fund size of $60 million and a life of 10 years. Mitsui Chemicals intends to enhance and strengthen its Basic Strategy of 'building solutions-based business models' as manifested in its Long-Term Business Plan, VISION 2030. Consistent with this goal, Mitsui Chemicals will continue investing in startups across the world to escalate the launching of new products and new businesses as well as the transformation of its business portfolio. Overview of 321Catalyst™, the new Corporate Venture Capital Fund Registered Name 321Catalyst LP Address San Jose, CA, USA Fund Size $60 million Date of Establishment May 6th, 2025 Fund Life 10 years Focus Stage Seed and at all stages beyond Focus Region Global (USA, Europe, Asia, etc.) Focus Industry All industries including Life & Healthcare, Mobility, ICT, Sustainability, and other new industries General Partner 321Catalyst Ventures, Inc. Limited Partner 321Indigo Ventures, Inc. (100% subsidiary of Mitsui Chemicals) Overview of the new subsidiary acting as the General Partner Registered Name 321Catalyst Ventures, Inc. Address San Jose, CA, USA Representative Shunsuke Fujii (President) Business Overview Management of Corporate Venture Capital Funds Date of Establishment April 10th, 2025 Ownership 100% owned by Mitsui Chemicals America, Inc View source version on Disclaimer: The above press release comes to you under an arrangement with Business Wire. Business Upturn takes no editorial responsibility for the same. Business Wire is an American company that disseminates full-text press releases from thousands of companies and organizations worldwide to news media, financial markets, disclosure systems, investors, information web sites, databases, bloggers, social networks and other audiences.
